Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
(Methyl)prednisolone and diazoxide in type 1 diabetes at onset
2018-000686-37Phase 4Completed
- Sponsor
- Leiden University Medical Center
- Start
- Aug 2019
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in diabetes mellitus type 1 (T1D) comparing Prednisolone + diazoxide with Placebo (2 arms). Primary endpoint: Primary endpoint at 24 months. Started Aug 2019; status: completed.
02
Drugs
prednisolonediazoxide
03
Conditions
diabetes mellitus type 1 (T1D)
Beyond the preview
Go deeper on 2018-000686-37.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2018-000686-37.